Similar articles

• Should patients stop taking aspirin for primary prevention?

  Depta JP, Bhatt DL. Depta JP, et al. Cleve Clin J Med. 2015 Feb;82(2):91-6. doi: 10.3949/ccjm.82a.14114. Cleve Clin J Med. 2015. PMID: 25897597 Review. No abstract available.
• Aspirin for the prevention of cardiovascular disease: recommendation statement.

  [No authors listed] [No authors listed] Am Fam Physician. 2011 Jun 15;83(12):1464-8. Am Fam Physician. 2011. PMID: 21671547 No abstract available.
• Bleeding risk with aspirin must be balanced against benefit.

  [No authors listed] [No authors listed] Harv Heart Lett. 2012 Aug;22(12):8. Harv Heart Lett. 2012. PMID: 23025025 No abstract available.
• Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.

  Morimoto T, Fukui T, Lee TH, Matsui K. Morimoto T, et al. Am J Med. 2004 Oct 1;117(7):459-68. doi: 10.1016/j.amjmed.2004.04.017. Am J Med. 2004. PMID: 15464702 Review.
• Aspirin for Primary Prevention Reduces Cardiovascular Events, Increases Bleeding Risk.

  Rosenberg K. Rosenberg K. Am J Nurs. 2019 May;119(5):66. doi: 10.1097/01.NAJ.0000557919.25989.80. Am J Nurs. 2019. PMID: 31033560 No abstract available.